IDH1/2 mutations and widespread hypermethylation of CpG islands represent the earliest known events in glioma development, preceding the acquisition of specific mutations in TP53 in astrocytomas or 1p/19q codeletion in oligodendrogliomas. Here, IDH1 is linked to central nervous system cancer.